Teladoc Health Analyst Price Targets

Wall Street analyst price targets and consensus rating for Teladoc Health (TDOC).

Price Target Range — 12 Quarters

Analyst Consensus — 20 Analysts

8Buy

12Hold

Consensus RatingHold# Analysts20Avg. Consensus PT$9Upside to Avg. PT+59.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 3, 2026	Citigroup	Daniel Grosslight	PT Cut	Neutral	$11→$8
Jul 30, 2026	Canaccord Genuity	Richard Close	PT Cut	Buy	$11→$10
Jul 30, 2026	Evercore ISI Group	Elizabeth Anderson	PT Cut	In-Line	$10→$8
Jul 21, 2026	Canaccord Genuity	Richard Close	PT Raise	Buy	$10→$11
Jul 7, 2026	B of A Securities	Allen Lutz	PT Raise	Buy	$9→$11
May 5, 2026	Citigroup	Daniel Grosslight	PT Raise	Neutral	$6→$7
Apr 8, 2026	Evercore ISI Group	Elizabeth Anderson	PT Raise	In-Line	$5→$6
Mar 26, 2026	Barclays	Glen Santangelo	PT Cut	Equal-Weight	$9→$7
Mar 13, 2026	JP Morgan	Lisa Gill	PT Cut	Neutral	$9→$7
Mar 10, 2026	B of A Securities	Allen Lutz	PT Raise	Buy	$7→$8
Mar 10, 2026	Deutsche Bank	George Hill	Upgrade	Hold→Buy	$11
Mar 3, 2026	Citigroup	Daniel Grosslight	PT Cut	Neutral	$9→$6
Mar 3, 2026	Oppenheimer	Michael Wiederhorn	PT Cut	Outperform	$12→$7
Feb 26, 2026	B of A Securities	Allen Lutz	Upgrade	Neutral→Buy	$7
Feb 26, 2026	Canaccord Genuity	Richard Close	PT Cut	Buy	$12→$10
Feb 26, 2026	Leerink Partners	Michael Cherny	PT Cut	Market Perform	$9→$6
Feb 26, 2026	TD Cowen	Charles Rhyee	PT Cut	Hold	$8→$6
Feb 26, 2026	BMO Capital	Sean Dodge	PT Cut	Market Perform	$8→$5
Feb 26, 2026	Piper Sandler	Jessica Tassan	PT Cut	Overweight	$12→$9
Feb 26, 2026	Evercore ISI Group	Elizabeth Anderson	PT Cut	In-Line	$8→$5

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Citigroup Maintains Neutral on Teladoc Health, Lowers Price Target to $7.5

Citigroup analyst Daniel Grosslight maintains Teladoc Health (NYSE:TDOC) with a Neutral and lowers the price target from $11 to $7.5.

Benzinga Newsdesk

PRO
Canaccord Genuity Maintains Buy on Teladoc Health, Lowers Price Target to $10

Canaccord Genuity analyst Richard Close maintains Teladoc Health (NYSE:TDOC) with a Buy and lowers the price target from $11 to $10.

Benzinga Newsdesk

PRO
Evercore ISI Group Maintains In-Line on Teladoc Health, Lowers Price Target to $7.5

Evercore ISI Group analyst Elizabeth Anderson maintains Teladoc Health (NYSE:TDOC) with a In-Line and lowers the price target from $10 to $7.5.

Benzinga Newsdesk

Synchrony Financial To Rally Around 25%? Here Are 10 Top Analyst Forecasts For Wednesday

Top analysts change outlook on top names. Baird, Canaccord Genuity, Needham, Stifel, Truist Securities raise price targets. See analyst ratings.

Avi Kapoor

PRO
Canaccord Genuity Maintains Buy on Teladoc Health, Raises Price Target to $11

Canaccord Genuity analyst Richard Close maintains Teladoc Health (NYSE:TDOC) with a Buy and raises the price target from $10 to $11.

Benzinga Newsdesk

PRO
Citigroup Maintains Neutral on Teladoc Health, Raises Price Target to $7

Citigroup analyst Daniel Grosslight maintains Teladoc Health (NYSE:TDOC) with a Neutral and raises the price target from $6 to $7.

Benzinga Newsdesk

Teladoc Health Inc

Teladoc Health Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Citigroup Maintains Neutral on Teladoc Health, Lowers Price Target to $7.5

PRO
Canaccord Genuity Maintains Buy on Teladoc Health, Lowers Price Target to $10

PRO
Evercore ISI Group Maintains In-Line on Teladoc Health, Lowers Price Target to $7.5

Synchrony Financial To Rally Around 25%? Here Are 10 Top Analyst Forecasts For Wednesday

PRO
Canaccord Genuity Maintains Buy on Teladoc Health, Raises Price Target to $11

PRO
Citigroup Maintains Neutral on Teladoc Health, Raises Price Target to $7

People Also Watch

People Also Watch

Teladoc Health Inc

Teladoc Health Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROCitigroup Maintains Neutral on Teladoc Health, Lowers Price Target to $7.5

PROCanaccord Genuity Maintains Buy on Teladoc Health, Lowers Price Target to $10

PROEvercore ISI Group Maintains In-Line on Teladoc Health, Lowers Price Target to $7.5

Synchrony Financial To Rally Around 25%? Here Are 10 Top Analyst Forecasts For Wednesday

PROCanaccord Genuity Maintains Buy on Teladoc Health, Raises Price Target to $11

PROCitigroup Maintains Neutral on Teladoc Health, Raises Price Target to $7

People Also Watch

People Also Watch

PRO
Citigroup Maintains Neutral on Teladoc Health, Lowers Price Target to $7.5

PRO
Canaccord Genuity Maintains Buy on Teladoc Health, Lowers Price Target to $10

PRO
Evercore ISI Group Maintains In-Line on Teladoc Health, Lowers Price Target to $7.5

PRO
Canaccord Genuity Maintains Buy on Teladoc Health, Raises Price Target to $11

PRO
Citigroup Maintains Neutral on Teladoc Health, Raises Price Target to $7